COMP360: Synthetic Psilocybin in Clinical Research

COMP360 is a proprietary, investigational formulation of synthetic psilocybin developed by Compass Pathways. The compound is being studied as a potential treatment for treatment-resistant depression (TRD) and post-traumatic stress disorder (PTSD). COMP360 has received FDA Breakthrough Therapy designation for TRD and remains an investigational product rather than an approved medicine. comp360 for sale

COMP360 is designed as a standardized pharmaceutical formulation of psilocybin for use in controlled clinical research. Research involving COMP360 examines how psychedelic-assisted treatment may affect symptoms of difficult-to-treat mental health conditions.

Compass Pathways has conducted extensive clinical research into COMP360, including large Phase 3 studies investigating its potential role in treatment-resistant depression.

Treatment-Resistant Depression

Clinical development of COMP360 has focused heavily on people with treatment-resistant depression, a condition in which depression symptoms have not adequately responded to previous treatments.

In 2026, Compass reported that its second Phase 3 TRD study, COMP006, achieved its primary endpoint. The company reported a statistically significant difference between the 25 mg and 1 mg groups at Week 6. These are company-reported clinical-trial findings and do not mean that COMP360 is currently an approved treatment.

The FDA granted Compass a request for rolling NDA submission and review in April 2026 based on Phase 3 data.

COMP360 and PTSD Research

COMP360 is also being investigated for post-traumatic stress disorder. An earlier Phase 2 study evaluated a single 25 mg dose in 22 participants and reported improvements in PTSD symptom measures over the 12-week follow-up period. Because the study was open-label and relatively small, its findings require confirmation through larger controlled studies.

Compass has subsequently advanced COMP360 into late-stage PTSD research.

Where to Buy

If you are searching for COMP360 for sale. Always follow the manufacturer’s directions and consult an appropriately qualified healthcare professional regarding medical use.

Psychedelic Discreet Shop is a trusted online store for purchasing COMP360 offering high-quality products, transparent sourcing, and a commitment to customer satisfaction. COMP360

Clinical Research Keywords

• COMP360
• COMP360 psilocybin
• COMP360 psilocybin research
• COMP360 clinical trial
• COMP360 clinical trials
• COMP360 Phase 3
• COMP360 treatment-resistant depression
• COMP360 TRD
• COMP360 PTSD
• COMP360 psychedelic research
• synthetic psilocybin COMP360
• COMP360 clinical research
• COMP360 clinical study
• COMP360 trial results
• COMP360 FDA
• Compass Pathways COMP360
• COMP360 psilocybin treatment
• COMP360 research study
• COMP360 psychedelic therapy
• COMP360 development